For patients with HR-, HER2+ EBC, tumor size ≥5 cm (compared with tumor size <1 cm) was associated with a significant increased risk of mortality (hazard ratio, 3.66; 95% CI, 2.23, 6.00; p<0.0001; Fig 4A). The gene discussed is ERBB2; the disease is neoplasm.